ID   PERM_HUMAN              Reviewed;         745 AA.
AC   P05164; A1L4B8; Q14862; Q4PJH5; Q9UCL7;
DT   13-AUG-1987, integrated into UniProtKB/Swiss-Prot.
DT   13-AUG-1987, sequence version 1.
DT   10-MAY-2017, entry version 203.
DE   RecName: Full=Myeloperoxidase;
DE            Short=MPO;
DE            EC=1.11.2.2 {ECO:0000269|PubMed:9922160};
DE   Contains:
DE     RecName: Full=Myeloperoxidase;
DE   Contains:
DE     RecName: Full=89 kDa myeloperoxidase;
DE   Contains:
DE     RecName: Full=84 kDa myeloperoxidase;
DE   Contains:
DE     RecName: Full=Myeloperoxidase light chain;
DE   Contains:
DE     RecName: Full=Myeloperoxidase heavy chain;
DE   Flags: Precursor;
GN   Name=MPO;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM H17).
RX   PubMed=3029127;
RA   Morishita K., Kubota N., Asano S., Kaziro Y., Nagata S.;
RT   "Molecular cloning and characterization of cDNA for human
RT   myeloperoxidase.";
RL   J. Biol. Chem. 262:3844-3851(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=2444596;
RA   Morishita K., Tsuchiya M., Asano S., Kaziro Y., Nagata S.;
RT   "Chromosomal gene structure of human myeloperoxidase and regulation of
RT   its expression by granulocyte colony-stimulating factor.";
RL   J. Biol. Chem. 262:15208-15213(1987).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM H17).
RX   PubMed=3654979; DOI=10.1172/JCI113181;
RA   Seto P., Hirayu H., Magnusson R.P., Gestautas J., Portmann L.,
RA   Degroot L.J., Rapoport B.;
RT   "Isolation of a complementary DNA clone for thyroid microsomal
RT   antigen. Homology with the gene for thyroid peroxidase.";
RL   J. Clin. Invest. 80:1205-1208(1987).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM H17).
RX   PubMed=3031585; DOI=10.1093/nar/15.5.2013;
RA   Johnson K.R., Nauseef W.M., Care A., Wheelock M.J., Shane S.,
RA   Hudson S., Koeffler H.P., Selsted M., Miller C., Rovera G.;
RT   "Characterization of cDNA clones for human myeloperoxidase: predicted
RT   amino acid sequence and evidence for multiple mRNA species.";
RL   Nucleic Acids Res. 15:2013-2028(1987).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS H7; H14 AND H17),
RP   AND PROTEIN SEQUENCE OF 165-183; 216-222; 295-304; 311-331; 464-479;
RP   662-676 AND 766-776.
RC   TISSUE=Leukemia;
RX   PubMed=2903767; DOI=10.1021/bi00416a013;
RA   Hashinaka K., Nishio C., Hur S.-J., Sakiyama F., Tsunasawa S.,
RA   Yamada M.;
RT   "Multiple species of myeloperoxidase messenger RNAs produced by
RT   alternative splicing and differential polyadenylation.";
RL   Biochemistry 27:5906-5914(1988).
RN   [6]
RP   ERRATUM.
RA   Hashinaka K., Nishio C., Hur S.-J., Sakiyama F., Tsunasawa S.,
RA   Yamada M.;
RL   Biochemistry 27:9226-9226(1988).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=2552418; DOI=10.1093/nar/17.19.7985;
RA   Johnson K.R., Gemperlein I., Hudson S., Shane S., Rovera G.;
RT   "Complete nucleotide sequence of the human myeloperoxidase gene.";
RL   Nucleic Acids Res. 17:7985-7986(1989).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM H17).
RX   PubMed=8383257;
RA   Hosokawa Y., Kawaguchi R., Hikiji K., Yamada M., Suzuki K.,
RA   Nakagawa T., Yoshihara T., Yamaguchi K.;
RT   "Cloning and characterization of four types of cDNA encoding
RT   myeloperoxidase from human monocytic leukemia cell line, SKM-1.";
RL   Leukemia 7:441-445(1993).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS PHE-53; CYS-604;
RP   GLN-683 AND VAL-717.
RG   NIEHS SNPs program;
RL   Submitted (JUN-2005) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM H17).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [12]
RP   PROTEIN SEQUENCE OF 49-66.
RX   PubMed=2154223; DOI=10.1016/0006-291X(90)90888-T;
RA   Yamada M., Hur S.-J., Toda H.;
RT   "Isolation and characterization of extracellular myeloperoxidase
RT   precursor in HL-60 cell cultures.";
RL   Biochem. Biophys. Res. Commun. 166:852-859(1990).
RN   [13]
RP   PROTEIN SEQUENCE OF 49-53, SUBUNIT, GLYCOSYLATION AT ASN-323; ASN-355;
RP   ASN-391; ASN-483 AND ASN-729, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=20332087; DOI=10.1074/jbc.M109.089748;
RA   Van Antwerpen P., Slomianny M.C., Boudjeltia K.Z., Delporte C.,
RA   Faid V., Calay D., Rousseau A., Moguilevsky N., Raes M., Vanhamme L.,
RA   Furtmueller P.G., Obinger C., Vanhaeverbeek M., Neve J.,
RA   Michalski J.C.;
RT   "Glycosylation pattern of mature dimeric leukocyte and recombinant
RT   monomeric myeloperoxidase: glycosylation is required for optimal
RT   enzymatic activity.";
RL   J. Biol. Chem. 285:16351-16359(2010).
RN   [14]
RP   PROTEIN SEQUENCE OF 279-424.
RC   TISSUE=Leukocyte;
RX   PubMed=1334087;
RA   Taylor K.L., Pohl J., Kinkade J.M. Jr.;
RT   "Unique autolytic cleavage of human myeloperoxidase. Implications for
RT   the involvement of active site MET409.";
RL   J. Biol. Chem. 267:25282-25288(1992).
RN   [15]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 548-629.
RX   PubMed=8390465;
RA   Yamada M., Yoshida M., Hashinaka K.;
RT   "Identification of transcriptional cis-elements in introns 7 and 9 of
RT   the myeloperoxidase gene.";
RL   J. Biol. Chem. 268:13479-13485(1993).
RN   [16]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 588-745.
RX   PubMed=2884926; DOI=10.1016/0003-9861(87)90304-3;
RA   Yamada M., Hur S.-J., Hashinaka K., Tsuneoka K., Saeki T., Nishio C.,
RA   Sakiyama F., Tsunasawa S.;
RT   "Isolation and characterization of a cDNA coding for human
RT   myeloperoxidase.";
RL   Arch. Biochem. Biophys. 255:147-155(1987).
RN   [17]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=9922160; DOI=10.1021/bi9818772;
RA   Furtmueller P.G., Burner U., Obinger C.;
RT   "Reaction of myeloperoxidase compound I with chloride, bromide,
RT   iodide, and thiocyanate.";
RL   Biochemistry 37:17923-17930(1998).
RN   [18]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-139 AND ASN-483.
RC   TISSUE=Plasma;
RX   PubMed=16335952; DOI=10.1021/pr0502065;
RA   Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,
RA   Moore R.J., Smith R.D.;
RT   "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,
RT   hydrazide chemistry, and mass spectrometry.";
RL   J. Proteome Res. 4:2070-2080(2005).
RN   [19]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-323 AND ASN-483.
RC   TISSUE=Saliva;
RX   PubMed=16740002; DOI=10.1021/pr050492k;
RA   Ramachandran P., Boontheung P., Xie Y., Sondej M., Wong D.T.,
RA   Loo J.A.;
RT   "Identification of N-linked glycoproteins in human saliva by
RT   glycoprotein capture and mass spectrometry.";
RL   J. Proteome Res. 5:1493-1503(2006).
RN   [20]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-355 AND ASN-391.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [21]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [22]
RP   X-RAY CRYSTALLOGRAPHY (1.75 ANGSTROMS) OF 167-744, AND SUBUNIT.
RX   PubMed=10766826; DOI=10.1074/jbc.275.16.11964;
RA   Fiedler T.J., Davey C.A., Fenna R.E.;
RT   "X-ray crystal structure and characterization of halide-binding sites
RT   of human myeloperoxidase at 1.8-A resolution.";
RL   J. Biol. Chem. 275:11964-11971(2000).
RN   [23]
RP   X-RAY CRYSTALLOGRAPHY (2.25 ANGSTROMS) OF 167-744, AND OXIDATION AT
RP   CYS-316.
RX   PubMed=7840679; DOI=10.1006/abbi.1995.1086;
RA   Fenna R.E., Zeng J., Davey C.;
RT   "Structure of the green heme in myeloperoxidase.";
RL   Arch. Biochem. Biophys. 316:653-656(1995).
RN   [24]
RP   X-RAY CRYSTALLOGRAPHY (1.85 ANGSTROMS) OF 167-744.
RX   PubMed=11705390; DOI=10.1021/bi0111808;
RA   Blair-Johnson M., Fiedler T., Fenna R.;
RT   "Human myeloperoxidase: structure of a cyanide complex and its
RT   interaction with bromide and thiocyanate substrates at 1.9 A
RT   resolution.";
RL   Biochemistry 40:13990-13997(2001).
RN   [25]
RP   VARIANT MPOD TRP-569.
RX   PubMed=8142659;
RA   Kizaki M., Miller C.W., Selsted M.E., Koeffler H.P.;
RT   "Myeloperoxidase (MPO) gene mutation in hereditary MPO deficiency.";
RL   Blood 83:1935-1940(1994).
RN   [26]
RP   VARIANT MPOD TRP-569.
RX   PubMed=7904599;
RA   Nauseef W.M., Brigham S., Cogley M.;
RT   "Hereditary myeloperoxidase deficiency due to a missense mutation of
RT   arginine 569 to tryptophan.";
RL   J. Biol. Chem. 269:1212-1216(1994).
RN   [27]
RP   CHARACTERIZATION OF VARIANT MPOD TRP-569.
RX   PubMed=8621627; DOI=10.1074/jbc.271.16.9546;
RA   Nauseef W., Cogley M., McCormick S.;
RT   "Effect of the R569W missense mutation on the biosynthesis of
RT   myeloperoxidase.";
RL   J. Biol. Chem. 271:9546-9549(1996).
RN   [28]
RP   VARIANT MPOD CYS-173, AND CHARACTERIZATION OF VARIANT MPOD CYS-173.
RX   PubMed=9637725; DOI=10.1172/JCI2649;
RA   DeLeo F.R., Goedken M., McCormick S.J., Nauseef W.M.;
RT   "A novel form of hereditary myeloperoxidase deficiency linked to
RT   endoplasmic reticulum/proteasome degradation.";
RL   J. Clin. Invest. 101:2900-2909(1998).
RN   [29]
RP   VARIANT MPOD THR-251.
RX   PubMed=9354683;
RA   Romano M., Dri P., Dadalt L., Patriarca P., Baralle F.E.;
RT   "Biochemical and molecular characterization of hereditary
RT   myeloperoxidase deficiency.";
RL   Blood 90:4126-4134(1997).
RN   [30]
RP   VARIANT [LARGE SCALE ANALYSIS] GLN-447.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Part of the host defense system of polymorphonuclear
CC       leukocytes. It is responsible for microbicidal activity against a
CC       wide range of organisms. In the stimulated PMN, MPO catalyzes the
CC       production of hypohalous acids, primarily hypochlorous acid in
CC       physiologic situations, and other toxic intermediates that greatly
CC       enhance PMN microbicidal activity. {ECO:0000269|PubMed:9922160}.
CC   -!- CATALYTIC ACTIVITY: Cl(-) + H(2)O(2) + H(+) = HClO + H(2)O.
CC       {ECO:0000269|PubMed:9922160}.
CC   -!- COFACTOR:
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108;
CC       Note=Binds 1 Ca(2+) ion per monomer.;
CC   -!- COFACTOR:
CC       Name=heme b; Xref=ChEBI:CHEBI:60344;
CC       Note=Binds 1 heme b (iron(II)-protoporphyrin IX) group covalently
CC       per monomer.;
CC   -!- SUBUNIT: Homodimer; disulfide-linked. Each monomer consists of a
CC       light and a heavy chain. {ECO:0000269|PubMed:10766826,
CC       ECO:0000269|PubMed:20332087}.
CC   -!- SUBCELLULAR LOCATION: Lysosome.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=H17; Synonyms=B;
CC         IsoId=P05164-1; Sequence=Displayed;
CC       Name=H14;
CC         IsoId=P05164-2; Sequence=VSP_007206;
CC       Name=H7; Synonyms=A;
CC         IsoId=P05164-3; Sequence=VSP_007207;
CC   -!- DISEASE: Myeloperoxidase deficiency (MPOD) [MIM:254600]: A
CC       disorder characterized by decreased myeloperoxidase activity in
CC       neutrophils and monocytes that results in disseminated
CC       candidiasis. {ECO:0000269|PubMed:7904599,
CC       ECO:0000269|PubMed:8142659, ECO:0000269|PubMed:8621627,
CC       ECO:0000269|PubMed:9354683, ECO:0000269|PubMed:9637725}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- SIMILARITY: Belongs to the peroxidase family. XPO subfamily.
CC       {ECO:0000255|PROSITE-ProRule:PRU00298}.
CC   -!- WEB RESOURCE: Name=MPObase; Note=MPO mutation db;
CC       URL="http://structure.bmc.lu.se/idbase/MPObase/";
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/mpo/";
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Myeloperoxidase entry;
CC       URL="https://en.wikipedia.org/wiki/Myeloperoxidase";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; J02694; AAA59896.1; -; mRNA.
DR   EMBL; M17176; AAA60346.1; -; Genomic_DNA.
DR   EMBL; M17170; AAA60346.1; JOINED; Genomic_DNA.
DR   EMBL; M17171; AAA60346.1; JOINED; Genomic_DNA.
DR   EMBL; M17172; AAA60346.1; JOINED; Genomic_DNA.
DR   EMBL; M17173; AAA60346.1; JOINED; Genomic_DNA.
DR   EMBL; M17174; AAA60346.1; JOINED; Genomic_DNA.
DR   EMBL; M17175; AAA60346.1; JOINED; Genomic_DNA.
DR   EMBL; X04876; CAA28565.1; -; mRNA.
DR   EMBL; M19507; AAA59863.1; -; mRNA.
DR   EMBL; M19508; AAA59864.1; -; Genomic_DNA.
DR   EMBL; M19508; AAA59865.1; -; Genomic_DNA.
DR   EMBL; X15377; CAA33438.1; -; Genomic_DNA.
DR   EMBL; S56200; AAB25582.1; -; mRNA.
DR   EMBL; DQ088846; AAY68218.1; -; Genomic_DNA.
DR   EMBL; CH471109; EAW94470.1; -; Genomic_DNA.
DR   EMBL; BC130476; AAI30477.1; -; mRNA.
DR   EMBL; D14466; BAA03362.1; -; Genomic_DNA.
DR   CCDS; CCDS11604.1; -. [P05164-1]
DR   PIR; A29467; OPHUM.
DR   PIR; B28894; B28894.
DR   PIR; D28894; D28894.
DR   RefSeq; NP_000241.1; NM_000250.1. [P05164-1]
DR   UniGene; Hs.458272; -.
DR   PDB; 1CXP; X-ray; 1.80 A; A/B=167-270, C/D=279-744.
DR   PDB; 1D2V; X-ray; 1.75 A; A/B=167-270, C/D=279-744.
DR   PDB; 1D5L; X-ray; 1.90 A; A/B=167-270, C/D=279-744.
DR   PDB; 1D7W; X-ray; 1.90 A; A/B=167-270, C/D=279-744.
DR   PDB; 1DNU; X-ray; 1.85 A; A/B=167-270, C/D=279-744.
DR   PDB; 1DNW; X-ray; 1.90 A; A/B=167-270, C/D=279-744.
DR   PDB; 1MHL; X-ray; 2.25 A; A/B=165-272, C/D=279-744.
DR   PDB; 1MYP; X-ray; 3.00 A; A/B=165-272, C/D=279-744.
DR   PDB; 3F9P; X-ray; 2.93 A; A/B=165-278, C/D=279-745.
DR   PDB; 3ZS0; X-ray; 2.30 A; A/B=165-272, C/D=279-745.
DR   PDB; 3ZS1; X-ray; 2.60 A; A/B=165-278, C/D=279-745.
DR   PDB; 4C1M; X-ray; 2.00 A; A/B=165-272, C/D=279-745.
DR   PDB; 4DL1; X-ray; 2.00 A; A/B/E/F/I/J/M/N=167-270, C/D/G/H/K/L/O/P=279-744.
DR   PDB; 4EJX; X-ray; 4.69 A; B=165-278, D=279-745.
DR   PDB; 5FIW; X-ray; 1.70 A; A/B=167-271, C/D=279-744.
DR   PDBsum; 1CXP; -.
DR   PDBsum; 1D2V; -.
DR   PDBsum; 1D5L; -.
DR   PDBsum; 1D7W; -.
DR   PDBsum; 1DNU; -.
DR   PDBsum; 1DNW; -.
DR   PDBsum; 1MHL; -.
DR   PDBsum; 1MYP; -.
DR   PDBsum; 3F9P; -.
DR   PDBsum; 3ZS0; -.
DR   PDBsum; 3ZS1; -.
DR   PDBsum; 4C1M; -.
DR   PDBsum; 4DL1; -.
DR   PDBsum; 4EJX; -.
DR   PDBsum; 5FIW; -.
DR   ProteinModelPortal; P05164; -.
DR   SMR; P05164; -.
DR   BioGrid; 110493; 6.
DR   IntAct; P05164; 3.
DR   MINT; MINT-1522833; -.
DR   STRING; 9606.ENSP00000225275; -.
DR   BindingDB; P05164; -.
DR   ChEMBL; CHEMBL2439; -.
DR   DrugBank; DB00233; Aminosalicylic Acid.
DR   DrugBank; DB00006; Bivalirudin.
DR   DrugBank; DB02300; Calcipotriol.
DR   DrugBank; DB06774; Capsaicin.
DR   DrugBank; DB00958; Carboplatin.
DR   DrugBank; DB00833; Cefaclor.
DR   DrugBank; DB00535; Cefdinir.
DR   DrugBank; DB00515; Cisplatin.
DR   DrugBank; DB00847; Cysteamine.
DR   DrugBank; DB00250; Dapsone.
DR   DrugBank; DB05161; Elafin.
DR   DrugBank; DB01225; Enoxaparin.
DR   DrugBank; DB04827; Ethyl carbamate.
DR   DrugBank; DB00062; Human Serum Albumin.
DR   DrugBank; DB00583; L-Carnitine.
DR   DrugBank; DB01065; Melatonin.
DR   DrugBank; DB00244; Mesalazine.
DR   DrugBank; DB00461; Nabumetone.
DR   DrugBank; DB04821; Nomifensine.
DR   DrugBank; DB00104; Octreotide.
DR   DrugBank; DB00526; Oxaliplatin.
DR   DrugBank; DB00550; Propylthiouracil.
DR   DrugBank; DB00208; Ticlopidine.
DR   DrugBank; DB06823; Tiopronin.
DR   DrugBank; DB00500; Tolmetin.
DR   GuidetoPHARMACOLOGY; 2789; -.
DR   PeroxiBase; 3315; HsMPO.
DR   iPTMnet; P05164; -.
DR   PhosphoSitePlus; P05164; -.
DR   SwissPalm; P05164; -.
DR   UniCarbKB; P05164; -.
DR   BioMuta; MPO; -.
DR   DMDM; 129825; -.
DR   EPD; P05164; -.
DR   PaxDb; P05164; -.
DR   PeptideAtlas; P05164; -.
DR   PRIDE; P05164; -.
DR   DNASU; 4353; -.
DR   Ensembl; ENST00000225275; ENSP00000225275; ENSG00000005381. [P05164-1]
DR   GeneID; 4353; -.
DR   KEGG; hsa:4353; -.
DR   UCSC; uc002ivu.1; human. [P05164-1]
DR   CTD; 4353; -.
DR   DisGeNET; 4353; -.
DR   GeneCards; MPO; -.
DR   H-InvDB; HIX0039242; -.
DR   HGNC; HGNC:7218; MPO.
DR   HPA; CAB000059; -.
DR   HPA; HPA021147; -.
DR   HPA; HPA061464; -.
DR   MalaCards; MPO; -.
DR   MIM; 254600; phenotype.
DR   MIM; 606989; gene.
DR   neXtProt; NX_P05164; -.
DR   OpenTargets; ENSG00000005381; -.
DR   Orphanet; 2587; Myeloperoxidase deficiency.
DR   PharmGKB; PA243; -.
DR   eggNOG; KOG2408; Eukaryota.
DR   eggNOG; ENOG410XPZ3; LUCA.
DR   GeneTree; ENSGT00550000074325; -.
DR   HOGENOM; HOG000016084; -.
DR   HOVERGEN; HBG000071; -.
DR   InParanoid; P05164; -.
DR   KO; K10789; -.
DR   OMA; KSSGCAY; -.
DR   OrthoDB; EOG091G02JC; -.
DR   PhylomeDB; P05164; -.
DR   TreeFam; TF314316; -.
DR   BioCyc; MetaCyc:HS00140-MONOMER; -.
DR   BRENDA; 1.11.2.2; 2681.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   SIGNOR; P05164; -.
DR   ChiTaRS; MPO; human.
DR   EvolutionaryTrace; P05164; -.
DR   GeneWiki; Myeloperoxidase; -.
DR   GenomeRNAi; 4353; -.
DR   PMAP-CutDB; P05164; -.
DR   PRO; PR:P05164; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000005381; -.
DR   CleanEx; HS_MPO; -.
DR   ExpressionAtlas; P05164; baseline and differential.
DR   Genevisible; P05164; HS.
DR   GO; GO:0042582; C:azurophil granule; IDA:UniProtKB.
DR   GO; GO:0035578; C:azurophil granule lumen; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; IDA:UniProtKB.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0005764; C:lysosome; TAS:ProtInc.
DR   GO; GO:0005739; C:mitochondrion; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0030141; C:secretory granule; IDA:MGI.
DR   GO; GO:0003682; F:chromatin binding; TAS:ProtInc.
DR   GO; GO:0020037; F:heme binding; IEA:InterPro.
DR   GO; GO:0008201; F:heparin binding; IDA:MGI.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004601; F:peroxidase activity; IDA:BHF-UCL.
DR   GO; GO:0007568; P:aging; IEA:Ensembl.
DR   GO; GO:0006952; P:defense response; TAS:ProtInc.
DR   GO; GO:0042742; P:defense response to bacterium; IBA:GO_Central.
DR   GO; GO:0050832; P:defense response to fungus; IEA:Ensembl.
DR   GO; GO:0042744; P:hydrogen peroxide catabolic process; IDA:BHF-UCL.
DR   GO; GO:0002149; P:hypochlorous acid biosynthetic process; IEA:Ensembl.
DR   GO; GO:0034374; P:low-density lipoprotein particle remodeling; IDA:BHF-UCL.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; TAS:ProtInc.
DR   GO; GO:0044130; P:negative regulation of growth of symbiont in host; IEA:Ensembl.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:0055114; P:oxidation-reduction process; IDA:BHF-UCL.
DR   GO; GO:0019430; P:removal of superoxide radicals; IEA:Ensembl.
DR   GO; GO:0002679; P:respiratory burst involved in defense response; IEA:Ensembl.
DR   GO; GO:0032094; P:response to food; IEA:Ensembl.
DR   GO; GO:1990268; P:response to gold nanoparticle; IEA:Ensembl.
DR   GO; GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl.
DR   GO; GO:0009612; P:response to mechanical stimulus; IEA:Ensembl.
DR   GO; GO:0006979; P:response to oxidative stress; TAS:UniProtKB.
DR   GO; GO:0001878; P:response to yeast; IEA:Ensembl.
DR   Gene3D; 1.10.640.10; -; 1.
DR   InterPro; IPR010255; Haem_peroxidase.
DR   InterPro; IPR019791; Haem_peroxidase_animal.
DR   InterPro; IPR029609; MPO.
DR   PANTHER; PTHR11475:SF93; PTHR11475:SF93; 1.
DR   Pfam; PF03098; An_peroxidase; 1.
DR   PRINTS; PR00457; ANPEROXIDASE.
DR   SUPFAM; SSF48113; SSF48113; 1.
DR   PROSITE; PS00435; PEROXIDASE_1; 1.
DR   PROSITE; PS50292; PEROXIDASE_3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Calcium; Complete proteome;
KW   Direct protein sequencing; Disease mutation; Disulfide bond;
KW   Glycoprotein; Heme; Hydrogen peroxide; Iron; Lysosome; Metal-binding;
KW   Nitration; Oxidation; Oxidoreductase; Peroxidase; Polymorphism;
KW   Reference proteome; Signal.
FT   SIGNAL        1     48       {ECO:0000269|PubMed:20332087,
FT                                ECO:0000269|PubMed:2154223}.
FT   CHAIN        49    745       89 kDa myeloperoxidase.
FT                                /FTId=PRO_0000023651.
FT   CHAIN       155    745       84 kDa myeloperoxidase.
FT                                /FTId=PRO_0000023653.
FT   CHAIN       165    745       Myeloperoxidase.
FT                                /FTId=PRO_0000023654.
FT   CHAIN       165    278       Myeloperoxidase light chain.
FT                                /FTId=PRO_0000023655.
FT   CHAIN       279    745       Myeloperoxidase heavy chain.
FT                                /FTId=PRO_0000023656.
FT   ACT_SITE    261    261       Proton acceptor.
FT   METAL       262    262       Calcium.
FT   METAL       334    334       Calcium.
FT   METAL       336    336       Calcium; via carbonyl oxygen.
FT   METAL       338    338       Calcium.
FT   METAL       340    340       Calcium.
FT   METAL       502    502       Iron (heme axial ligand).
FT   BINDING     260    260       Heme (covalent; via 3 links).
FT   BINDING     408    408       Heme (covalent; via 3 links).
FT   BINDING     409    409       Heme (covalent; via 3 links).
FT   SITE        405    405       Transition state stabilizer.
FT   MOD_RES     316    316       Cysteine sulfenic acid (-SOH).
FT                                {ECO:0000269|PubMed:7840679}.
FT   MOD_RES     516    516       Nitrated tyrosine.
FT                                {ECO:0000250|UniProtKB:P11678}.
FT   CARBOHYD    139    139       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:16335952}.
FT   CARBOHYD    323    323       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:16740002,
FT                                ECO:0000269|PubMed:20332087}.
FT   CARBOHYD    355    355       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218,
FT                                ECO:0000269|PubMed:20332087}.
FT   CARBOHYD    391    391       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218,
FT                                ECO:0000269|PubMed:20332087}.
FT   CARBOHYD    483    483       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:16335952,
FT                                ECO:0000269|PubMed:16740002,
FT                                ECO:0000269|PubMed:20332087}.
FT                                /FTId=CAR_000220.
FT   CARBOHYD    729    729       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:20332087}.
FT   DISULFID    167    180
FT   DISULFID    281    291
FT   DISULFID    285    309
FT   DISULFID    319    319       Interchain.
FT   DISULFID    387    398
FT   DISULFID    606    663
FT   DISULFID    704    730
FT   VAR_SEQ       1     95       Missing (in isoform H14).
FT                                {ECO:0000303|PubMed:2903767}.
FT                                /FTId=VSP_007206.
FT   VAR_SEQ     182    182       N -> NRCGWLGVAAGTGLREASRTPQASRCQRPVLPC
FT                                (in isoform H7).
FT                                {ECO:0000303|PubMed:2903767}.
FT                                /FTId=VSP_007207.
FT   VARIANT      53     53       V -> F (in dbSNP:rs7208693).
FT                                {ECO:0000269|Ref.9}.
FT                                /FTId=VAR_023995.
FT   VARIANT     173    173       Y -> C (in MPOD; affects proteolytic
FT                                processing and secretion;
FT                                dbSNP:rs78950939).
FT                                {ECO:0000269|PubMed:9637725}.
FT                                /FTId=VAR_015377.
FT   VARIANT     251    251       M -> T (in MPOD; dbSNP:rs56378716).
FT                                {ECO:0000269|PubMed:9354683}.
FT                                /FTId=VAR_015378.
FT   VARIANT     447    447       R -> Q (in a colorectal cancer sample;
FT                                somatic mutation; dbSNP:rs762688992).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_036517.
FT   VARIANT     569    569       R -> W (in MPOD; suppress post-
FT                                translational processing;
FT                                dbSNP:rs119468010).
FT                                {ECO:0000269|PubMed:7904599,
FT                                ECO:0000269|PubMed:8142659,
FT                                ECO:0000269|PubMed:8621627}.
FT                                /FTId=VAR_015379.
FT   VARIANT     604    604       R -> C (in dbSNP:rs35670089).
FT                                {ECO:0000269|Ref.9}.
FT                                /FTId=VAR_023996.
FT   VARIANT     683    683       E -> Q (in dbSNP:rs35702888).
FT                                {ECO:0000269|Ref.9}.
FT                                /FTId=VAR_023997.
FT   VARIANT     717    717       I -> V (in dbSNP:rs2759).
FT                                {ECO:0000269|Ref.9}.
FT                                /FTId=VAR_012066.
FT   CONFLICT     36     36       L -> V (in Ref. 4; CAA28565 and 7;
FT                                CAA33438). {ECO:0000305}.
FT   STRAND      181    185       {ECO:0000244|PDB:5FIW}.
FT   TURN        186    189       {ECO:0000244|PDB:5FIW}.
FT   STRAND      191    194       {ECO:0000244|PDB:5FIW}.
FT   STRAND      206    208       {ECO:0000244|PDB:5FIW}.
FT   STRAND      218    223       {ECO:0000244|PDB:1MYP}.
FT   HELIX       227    234       {ECO:0000244|PDB:5FIW}.
FT   HELIX       239    241       {ECO:0000244|PDB:5FIW}.
FT   STRAND      244    249       {ECO:0000244|PDB:5FIW}.
FT   HELIX       250    263       {ECO:0000244|PDB:5FIW}.
FT   TURN        281    283       {ECO:0000244|PDB:5FIW}.
FT   STRAND      317    319       {ECO:0000244|PDB:5FIW}.
FT   STRAND      323    325       {ECO:0000244|PDB:5FIW}.
FT   STRAND      329    331       {ECO:0000244|PDB:5FIW}.
FT   STRAND      335    338       {ECO:0000244|PDB:5FIW}.
FT   HELIX       340    343       {ECO:0000244|PDB:5FIW}.
FT   HELIX       347    352       {ECO:0000244|PDB:5FIW}.
FT   STRAND      357    360       {ECO:0000244|PDB:5FIW}.
FT   STRAND      371    374       {ECO:0000244|PDB:1MYP}.
FT   HELIX       386    389       {ECO:0000244|PDB:5FIW}.
FT   TURN        392    394       {ECO:0000244|PDB:5FIW}.
FT   STRAND      401    403       {ECO:0000244|PDB:1MYP}.
FT   TURN        404    407       {ECO:0000244|PDB:5FIW}.
FT   HELIX       410    433       {ECO:0000244|PDB:5FIW}.
FT   HELIX       439    460       {ECO:0000244|PDB:5FIW}.
FT   HELIX       463    467       {ECO:0000244|PDB:5FIW}.
FT   HELIX       469    475       {ECO:0000244|PDB:5FIW}.
FT   HELIX       494    497       {ECO:0000244|PDB:5FIW}.
FT   HELIX       498    504       {ECO:0000244|PDB:5FIW}.
FT   STRAND      507    510       {ECO:0000244|PDB:5FIW}.
FT   STRAND      516    518       {ECO:0000244|PDB:5FIW}.
FT   STRAND      523    526       {ECO:0000244|PDB:5FIW}.
FT   HELIX       527    529       {ECO:0000244|PDB:5FIW}.
FT   TURN        530    532       {ECO:0000244|PDB:5FIW}.
FT   HELIX       534    539       {ECO:0000244|PDB:5FIW}.
FT   HELIX       544    551       {ECO:0000244|PDB:5FIW}.
FT   STRAND      552    556       {ECO:0000244|PDB:5FIW}.
FT   HELIX       566    569       {ECO:0000244|PDB:5FIW}.
FT   TURN        573    576       {ECO:0000244|PDB:5FIW}.
FT   STRAND      577    579       {ECO:0000244|PDB:5FIW}.
FT   HELIX       583    593       {ECO:0000244|PDB:5FIW}.
FT   HELIX       599    605       {ECO:0000244|PDB:5FIW}.
FT   HELIX       614    621       {ECO:0000244|PDB:5FIW}.
FT   HELIX       624    634       {ECO:0000244|PDB:5FIW}.
FT   HELIX       637    639       {ECO:0000244|PDB:5FIW}.
FT   HELIX       642    648       {ECO:0000244|PDB:5FIW}.
FT   STRAND      655    657       {ECO:0000244|PDB:5FIW}.
FT   HELIX       659    674       {ECO:0000244|PDB:5FIW}.
FT   TURN        683    685       {ECO:0000244|PDB:1D2V}.
FT   HELIX       688    694       {ECO:0000244|PDB:5FIW}.
FT   HELIX       699    706       {ECO:0000244|PDB:5FIW}.
FT   STRAND      711    713       {ECO:0000244|PDB:5FIW}.
FT   TURN        717    719       {ECO:0000244|PDB:5FIW}.
FT   TURN        723    726       {ECO:0000244|PDB:5FIW}.
FT   STRAND      727    729       {ECO:0000244|PDB:5FIW}.
FT   HELIX       730    732       {ECO:0000244|PDB:5FIW}.
FT   HELIX       739    741       {ECO:0000244|PDB:5FIW}.
SQ   SEQUENCE   745 AA;  83869 MW;  348B1CE0A11038B4 CRC64;
     MGVPFFSSLR CMVDLGPCWA GGLTAEMKLL LALAGLLAIL ATPQPSEGAA PAVLGEVDTS
     LVLSSMEEAK QLVDKAYKER RESIKQRLRS GSASPMELLS YFKQPVAATR TAVRAADYLH
     VALDLLERKL RSLWRRPFNV TDVLTPAQLN VLSKSSGCAY QDVGVTCPEQ DKYRTITGMC
     NNRRSPTLGA SNRAFVRWLP AEYEDGFSLP YGWTPGVKRN GFPVALARAV SNEIVRFPTD
     QLTPDQERSL MFMQWGQLLD HDLDFTPEPA ARASFVTGVN CETSCVQQPP CFPLKIPPND
     PRIKNQADCI PFFRSCPACP GSNITIRNQI NALTSFVDAS MVYGSEEPLA RNLRNMSNQL
     GLLAVNQRFQ DNGRALLPFD NLHDDPCLLT NRSARIPCFL AGDTRSSEMP ELTSMHTLLL
     REHNRLATEL KSLNPRWDGE RLYQEARKIV GAMVQIITYR DYLPLVLGPT AMRKYLPTYR
     SYNDSVDPRI ANVFTNAFRY GHTLIQPFMF RLDNRYQPME PNPRVPLSRV FFASWRVVLE
     GGIDPILRGL MATPAKLNRQ NQIAVDEIRE RLFEQVMRIG LDLPALNMQR SRDHGLPGYN
     AWRRFCGLPQ PETVGQLGTV LRNLKLARKL MEQYGTPNNI DIWMGGVSEP LKRKGRVGPL
     LACIIGTQFR KLRDGDRFWW ENEGVFSMQQ RQALAQISLP RIICDNTGIT TVSKNNIFMS
     NSYPRDFVNC STLPALNLAS WREAS
//
